Michael Danzi holds a BS in Engineering from Cornell University and an MBA from Harvard Business School. He also completed the US Naval Nuclear Power School’s graduate engineering program.

Michael has more than twenty years experience running pharmaceutical companies, producing topical pharmaceuticals used in eye and skin care, buccal surgery healing, and skin cancer treatment.

Over the past 30 years, he has held Founder, CEO, COO, and Board of Director level positions at private and public healthcare companies, including global pharmaceutical companies ICN Pharmaceuticals International and Legacy Pharmaceuticals International, as well as diagnostics companies like BioTek Solutions/Ventana Medical Systems and US Labs.

Video: DermDefense, Inc – Product Development

The post Michael Danzi, BSE, MBA first appeared on Derm Defense Inc..

Richard Kristof is an executive with a background in software technology, adult learning, financial services, and business development with over 25 years of experience building massively scalable applications for the learning and financial industries. 

He has twelve acquisitions totaling over $330 million to his credit, along with the startup and operation of several businesses and two bestselling book series with over 1.5 million copies sold.  His work in financial services is a natural extension of his M&A background and history as a Series 6/63 licensed dealer.

Richard also serves as Chief Strategy Officer for Global Verification Network, a background verification company specializing in vetting individuals for financial transactions. His work in business consulting includes a Managing Director role with Authentic Business Intelligence Alliance, a company specializing in consulting services, training, and technology consulting. 

Richard serves on several Boards of Directors and in an advisory capacity with select companies and works with startup companies across a variety of industries.

Videos:

Investor Relations and Business Strategy for DermDefense, Inc.

Strengths of DermDefense, Inc.

The post Richard Kristof first appeared on Derm Defense Inc..

Sandra Chansler has mastered the skincare industry for more than 30 years, with two decades of experience in cosmetics and laser treatments. She is a certified laser specialist, medical assistant, and licensed aesthetician. She has also played an instrumental role in training physicians on CO2 laser technology and has personally performed 10,000 plus hours of laser procedures.

Ms. Chansler developed the formulation, SM-1997, after discovering its incredible ability to heal difficult wounds. In 2006, she and Co-Founder, Neal Andrews, were approached by Dr. John S. Graham PhD of the US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD after hearing about SM-1997.

As the National Sales Director for the American Institute of Esthetics, Ms. Chansler was responsible for all field sales, customer service, product design, and marketing. She also served as President for Esthetician’s Formula Inc., where she was responsible for sales, product development, and customer product training.

Prior to starting DermDefense Inc, Ms. Chansler founded a skincare brand where she still serves as president. She was one of the early skincare pioneers who recognized the amazing benefits of using hyaluronic acid as a cosmetics additive for skin rejuvenation and repair and developed a specialized formula for her brand.

The post Sandra Chansler first appeared on Derm Defense Inc..

Neal W. Andrews is President and CEO of DermDefense, Inc. and 1997 Holding, Inc. Mr. Andrews is a disabled veteran, focused on serving his country with this honorable mission of gaining approval for SM-1997 to be used in the treatment of sulfur mustard-induced skin injuries. 

His extensive experience in military and scientific research includes established relationships with a variety of agencies, including the Defense Threat Reduction Agency (DTRA), Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), Counter Act, the U.S. Army Medical Logistics Command (USAMMA), and the US-NATO partner community.

Mr. Andrews has worked with and for the benefit of SM-1997 with a variety of key experts including the following people and organizations:

• Senior Staff of U.S. Army Medical Research Institute of Chemical Defense (USAMRICD)
• Senior Staff of USAMMA at Fort Detrick
• Senior Staff Countermeasures Against Chemical Threats (CounterACT) Program
• Senior Staff at the National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services (HHS)
• Senior Staff at BARDA
• Senior Staff at MRI Global
• Senior Staff at Battelle Biomedical
• Senior Staff of Bundeswehr, Institute of Pharmacology and Toxicology (German Army) Munchen, Germany
• Team members at the Institute for Biological Research (IIBR)

Mr. Andrews has gathered together an outstanding team for DermDefense that includes an FDA regulatory team of experts, a science team, and a variety of international consultants to ensure that DermDefense secures new drug approval by the FDA, including a coveted Priority Review Voucher.  

Mr. Andrews has been integrally involved in the development of the protocols that provide the basis for DermDefense Inc’s current project and will continue in this role to help develop research protocols, methodology, formulation strength, and will review and analyze the data results through final FDA approval.

Video: Introduction to DermDefense, Inc.

The post Neal Andrews first appeared on Derm Defense Inc..